InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

- Current share price for GSS : $0.058

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Notification of cessation of securities - GSS 28 Jun 2024 1:58PM $0.720 $0.058 fallen by 91.94%
$13 Change of Director's Interest Notice 26 Jun 2024 5:19PM $0.710 $0.058 fallen by 91.83%
$13 Change in substantial holding 17 Jun 2024 4:56PM $0.675 $0.058 fallen by 91.41%
$13 Becoming a substantial holder 17 Jun 2024 4:47PM $0.675 $0.058 fallen by 91.41%
$13 Change in substantial holding 17 Jun 2024 2:14PM $0.680 $0.058 fallen by 91.47%
$13 Cleansing Notice 13 Jun 2024 9:52AM $0.720 $0.058 fallen by 91.94%
$13 Application for quotation of securities - GSS 13 Jun 2024 9:49AM $0.720 $0.058 fallen by 91.94%
$13 Letter To Ineligible Shareholders 12 Jun 2024 9:46AM $0.745 $0.058 fallen by 92.21%
$13 Letter To Eligible Retail Shareholders 12 Jun 2024 9:46AM $0.745 $0.058 fallen by 92.21%
$13 Despatch Of Retail Entitlement Offer Booklet 12 Jun 2024 9:45AM $0.745 $0.058 fallen by 92.21%
$13 Completion of Institutional Entitlement Offer and Placement 6 Jun 2024 9:10AM $0.730 $0.058 fallen by 92.05%
$13 Proposed issue of securities - GSS 4 Jun 2024 9:42AM $0.730 $0.058 fallen by 92.05%
$13 Proposed issue of securities - GSS 4 Jun 2024 9:42AM $0.730 $0.058 fallen by 92.05%
$13 Entitlement Offer Cleansing Notice 4 Jun 2024 9:41AM $0.730 $0.058 fallen by 92.05%
$13 FDA Clearance and Capital Raising Presentation 4 Jun 2024 9:41AM $0.730 $0.058 fallen by 92.05%
$13 Genetic Signatures Announces $30 Million Capital Raising 4 Jun 2024 9:38AM $0.730 $0.058 fallen by 92.05%
$13 Genetic Signatures Appoints Allison Rossiter As CEO 4 Jun 2024 9:34AM $0.730 $0.058 fallen by 92.05%
$13 FDA Clearance For Gastrointestinal Parasite Detection Kit 4 Jun 2024 9:34AM $0.730 $0.058 fallen by 92.05%
$13 Trading Halt 31 May 2024 9:55AM $0.730 $0.058 fallen by 92.05%
$13 Decision to Cease Development of US Respiratory Product 27 May 2024 8:39AM $0.730 $0.058 fallen by 92.05%
$13 Ceasing to be a substantial holder 7 May 2024 4:44PM $0.720 $0.058 fallen by 91.94%
$13 Application for quotation of securities - GSS 3 May 2024 1:46PM $0.705 $0.058 fallen by 91.77%
$13 Final Director's Interest Notice 30 Apr 2024 6:22PM $0.695 $0.058 fallen by 91.65%
$13 Leadership Transition at Genetic Signatures 30 Apr 2024 9:28AM $0.700 $0.058 fallen by 91.71%
$13 Quarterly Activities/Appendix 4C Cash Flow Report 26 Apr 2024 12:04PM $0.650 $0.058 fallen by 91.08%

101 - 125 of 504 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.